Full Text
EE247 Emicizumab is Cost-Saving for Finnish Hemophilia A Patients with Factor VIII Inhibitors

Abstract

Authors

A.M. Viita E. Prada Conejero J. Laine

Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×